Molecular Epidemiology and Diversity of SARS-CoV-2 in Ethiopia, 2020-2022

Genes (Basel). 2023 Mar 13;14(3):705. doi: 10.3390/genes14030705.

Abstract

Ethiopia is the second most populous country in Africa and the sixth most affected by COVID-19 on the continent. Despite having experienced five infection waves, >499,000 cases, and ~7500 COVID-19-related deaths as of January 2023, there is still no detailed genomic epidemiological report on the introduction and spread of SARS-CoV-2 in Ethiopia. In this study, we reconstructed and elucidated the COVID-19 epidemic dynamics. Specifically, we investigated the introduction, local transmission, ongoing evolution, and spread of SARS-CoV-2 during the first four infection waves using 353 high-quality near-whole genomes sampled in Ethiopia. Our results show that whereas viral introductions seeded the first wave, subsequent waves were seeded by local transmission. The B.1.480 lineage emerged in the first wave and notably remained in circulation even after the emergence of the Alpha variant. The B.1.480 was outcompeted by the Delta variant. Notably, Ethiopia's lack of local sequencing capacity was further limited by sporadic, uneven, and insufficient sampling that limited the incorporation of genomic epidemiology in the epidemic public health response in Ethiopia. These results highlight Ethiopia's role in SARS-CoV-2 dissemination and the urgent need for balanced, near-real-time genomic sequencing.

Keywords: COVID-19; Ethiopia; SARS-CoV-2; molecular epidemiology; whole genome sequence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19* / epidemiology
  • COVID-19* / genetics
  • Ethiopia / epidemiology
  • Humans
  • Molecular Epidemiology
  • SARS-CoV-2* / genetics

Supplementary concepts

  • SARS-CoV-2 variants

Grants and funding

This research was financed by Addis Ababa University through the COVID-19-AAU research fund for staff with reference #-PR/5.15/590/12/20 and adaptive research and problem-solving projects with references #AR/043/2021 and RD/PY-148/2021. In addition, this work was realized by the generous financial and technical support of the AU through Africa CDC, PGI. No more external funding was received. The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript. The contents are purely the responsibilities of the authors and do not represent or reflect the views of the funders.